Entity Central Index Key
Cover [Abstract]
Document Type
Document Type
Document Annual Report
Document Annual Report
Document Transition Report
Document Transition Report
Document Period End Date
Document Period End Date
Entity File Number
Entity File Number
Entity Registrant Name
Entity Registrant Name
Entity Incorporation, State or Country Code
Entity Incorporation State Country Code
Entity Tax Identification Number
Entity Tax Identification Number
Entity Address, Address Line One
Entity Address Address Line1
Entity Address, Address Line Two
Entity Address Address Line2
Entity Address, City or Town
Entity Address City Or Town
Entity Address, State or Province
Entity Address State Or Province
Entity Address, Postal Zip Code
Entity Address Postal Zip Code
City Area Code
City Area Code
Local Phone Number
Local Phone Number
Title of 12(b) Security
Security12b Title
Trading Symbol
Trading Symbol
Security Exchange Name
Security Exchange Name
Entity Current Reporting Status
Entity Current Reporting Status
Entity Interactive Data Current
Entity Interactive Data Current
Entity Filer Category
Entity Filer Category
Entity Small Business
Entity Small Business
Entity Emerging Growth Company
Entity Emerging Growth Company
Entity Shell Company
Entity Shell Company
Entity Common Stock, Shares Outstanding
Entity Common Stock Shares Outstanding
Current Fiscal Year End Date
Current Fiscal Year End Date
Document Fiscal Year Focus
Document Fiscal Year Focus
Document Fiscal Period Focus
Document Fiscal Period Focus
Entity Central Index Key
Amendment Flag
Amendment Flag
ICFR Auditor Attestation Flag
Icfr Auditor Attestation Flag
Entity Well-known Seasoned Issuer
Entity Well Known Seasoned Issuer
Entity Voluntary Filers
Entity Voluntary Filers
Entity Public Float
Entity Public Float
Statement Of Financial Position [Abstract]
Assets
Assets [Abstract]
Current assets:
Assets Current [Abstract]
Cash and cash equivalents
Cash And Cash Equivalents At Carrying Value
Prepaid and other current assets
Prepaid Expense And Other Assets Current
Total current assets
Assets Current
Equipment, net
Property Plant And Equipment Net
Right-of-use asset - operating lease
Operating Lease Right Of Use Asset
Other assets
Other Assets Noncurrent
Total assets
Assets
Liabilities and stockholders’ equity
Liabilities And Stockholders Equity [Abstract]
Current liabilities:
Liabilities Current [Abstract]
Accounts payable
Accounts Payable Current
Accrued expenses and other current liabilities
Accounts Payable And Other Accrued Liabilities Current
Operating lease liability, current portion
Operating Lease Liability Current
Loan payable, current portion
Long Term Debt Current
Total current liabilities
Liabilities Current
Loan payable, long-term
Long Term Debt Noncurrent
Operating lease liability, long-term
Operating Lease Liability Noncurrent
Total liabilities
Liabilities
Stockholders’ equity:
Stockholders Equity [Abstract]
Preferred stock, $0.0001 par value per share (10,000,000 shares authorized, none issued and outstanding at December 31, 2020 and December 31, 2019, respectively)
Preferred Stock Value
Common stock, $0.0001 par value per share (150,000,000 shares authorized, 37,374,088 and 36,933,217 shares issued and outstanding at December 31, 2020 and December 31, 2019, respectively)
Common Stock Value
Additional paid-in capital
Additional Paid In Capital Common Stock
Accumulated deficit
Retained Earnings Accumulated Deficit
Total stockholders’ equity
Stockholders Equity
Total liabilities and stockholders’ equity
Liabilities And Stockholders Equity
Preferred stock, par value
Preferred Stock Par Or Stated Value Per Share
Preferred stock, shares authorized
Preferred Stock Shares Authorized
Preferred stock, shares issued
Preferred Stock Shares Issued
Preferred stock, shares outstanding
Preferred Stock Shares Outstanding
Common stock, par value
Common Stock Par Or Stated Value Per Share
Common stock, shares authorized
Common Stock Shares Authorized
Common stock, shares issued
Common Stock Shares Issued
Common stock, shares outstanding
Common Stock Shares Outstanding
Represents the amount of other income from NYC Biotechnology Credit.
Income Statement [Abstract]
Operating expenses:
Operating Expenses [Abstract]
Research and development
Research And Development Expense
General and administrative
General And Administrative Expense
Total operating expenses
Operating Expenses
Loss from operations
Operating Income Loss
Interest and amortization of debt discount expense
Investment Income Net
Tax credit
Income From N Y C Biotechnology Credit
Change in fair value of warrant liability
Fair Value Adjustment Of Warrants
Loss on extinguishment of debt
Gains Losses On Extinguishment Of Debt
Net loss
Net Income Loss
Net loss per common share, basic and diluted
Earnings Per Share Basic And Diluted
Weighted average common shares outstanding, basic and diluted
Weighted Average Number Of Share Outstanding Basic And Diluted
Number of shares of stock issued as a result of the exercise of warrants.
Value of stock issued as a result of the exercise of warrants.
Value of warrants issued during period with debt financing.
Number of shares of stock issued during the period pursuant to a financing arrangement.
Value of stock issued pursuant to a financing arrangement during the period.
Statement Of Stockholders Equity [Abstract]
Statement [Table]
Statement [Table]
Equity Components
Statement Equity Components [Axis]
Equity Component
Equity Component [Domain]
Common Stock
Common Stock [Member]
Additional Paid-in Capital
Additional Paid In Capital [Member]
Accumulated Deficit
Retained Earnings [Member]
Research and Development Arrangement, Contract to Perform for Others, Type
Research And Development Arrangement Contract To Perform For Others By Type [Axis]
Research and Development Arrangement, Contract to Perform for Others, Type
Research And Development Arrangement Contract To Perform For Others Type [Domain]
License Agreement
License Agreement Terms [Member]
Statement [Line Items]
Statement [Line Items]
Beginning balance
Balance (in shares)
Stock-based compensation
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
Issuance of common stock upon exercise of options
Stock Issued During Period Value Stock Options Exercised
Issuance of common stock upon exercise of options (in shares)
Stock Issued During Period Shares Stock Options Exercised
Exercise of warrants
Stock Issued During Period Value Warrants Exercised
Exercise of warrants (in shares)
Stock Issued During Period Shares Stock Warrants Exercised
Issuance of warrants upon debt financing
Warrants Issued During Period Debt Financing
Issuance of common stock upon financing
Stock Issued During Period Value Financing
Issuance of common stock upon financing (in shares)
Stock Issued During Period Shares Financing
Net loss
Ending balance
Balance (in shares)
The aggregate noncash costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.
Change in operating lease liability.
The increase (decrease) during the reporting period in the value of prepaid expenses and other current assets not separately disclosed in the statement of cash flows, for example, deferred expenses, intangible assets, or income taxes.
Warrants issued with debt financing.
Statement Of Cash Flows [Abstract]
Cash flows from operating activities
Net Cash Provided By Used In Operating Activities [Abstract]
Net loss
Profit Loss
Adjustments to reconcile net loss to net cash used in operating activities:
Adjustments Noncash Items To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities [Abstract]
Stock-based compensation expense
Share Based Compensation
Non-cash research and development license expense
Noncash Research And Development Expense
Amortization of debt discount
Amortization Of Debt Discount Premium
Loss on extinguishment of debt
Amortization of operating lease right-of-use asset
Operating Lease Right Of Use Asset Amortization Expense
Change in fair value of warrants
Change in operating lease liability
Change In Operating Lease Liability
Depreciation
Depreciation
Changes in operating assets and liabilities:
Increase Decrease In Operating Capital [Abstract]
Prepaid expenses and other current assets
Increase Decrease In Prepaid Expense And Other Assets Current
Other assets
Increase Decrease In Other Noncurrent Assets
Accounts payable
Increase Decrease In Accounts Payable
Accrued expenses and other current liabilities
Increase Decrease In Other Accounts Payable And Accrued Liabilities
Net cash used in operating activities
Net Cash Provided By Used In Operating Activities
Cash flows from investing activities
Net Cash Provided By Used In Investing Activities [Abstract]
Purchases of equipment
Payments To Acquire Property Plant And Equipment
Net cash used in investing activities
Net Cash Provided By Used In Investing Activities
Cash flows from financing activities
Net Cash Provided By Used In Financing Activities [Abstract]
Proceeds from issuance of term loan
Proceeds From Issuance Of Long Term Debt
Payment of debt issuance costs
Payments Of Debt Issuance Costs
Repayment of principal on term loan
Repayments Of Long Term Debt
Proceeds from issuance of common stock upon financing, net
Proceeds From Issuance Of Common Stock
Proceeds from issuance of common stock upon exercise of warrants
Proceeds From Warrant Exercises
Proceeds from issuance of common stock upon exercise of options
Proceeds From Stock Options Exercised
Net cash provided by financing activities
Net Cash Provided By Used In Financing Activities
Net (decrease) increase in cash
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
Cash at beginning of period
Cash
Cash at end of period
Supplemental disclosures of cash flow information:
Supplemental Cash Flow Information [Abstract]
Interest paid
Interest Paid Net
Operating lease right-of-use asset obtained in exchange for operating lease liability
Right Of Use Asset Obtained In Exchange For Operating Lease Liability
Supplemental disclosures of non-cash financing activity:
Cash Flow Noncash Investing And Financing Activities Disclosure [Abstract]
Issuance of warrants in connection with debt financing
Warrants Issued With Debt Financing
Documents Incorporated by Reference
Documents Incorporated By Reference [Text Block]
Organization Consolidation And Presentation Of Financial Statements [Abstract]
Nature of Business and Basis of Presentation
Organization Consolidation And Presentation Of Financial Statements Disclosure [Text Block]
Accounting Policies [Abstract]
Summary of Significant Accounting Policies
Significant Accounting Policies [Text Block]
Fair Value Disclosures [Abstract]
Fair Value Measurements
Fair Value Disclosures [Text Block]
Earnings Per Share [Abstract]
Net Loss per Common Share
Earnings Per Share [Text Block]
Accrued Liabilities And Other Liabilities [Abstract]
Accrued Expenses and Other Current Liabilities
Accounts Payable And Accrued Liabilities Disclosure [Text Block]
Debt Disclosure [Abstract]
Loan and Security Agreement
Long Term Debt [Text Block]
Commitments And Contingencies Disclosure [Abstract]
Commitments and Contingencies
Commitments And Contingencies Disclosure [Text Block]
Equity [Abstract]
Stockholders' Equity
Stockholders Equity Note Disclosure [Text Block]
The entire disclosure for warrants and rights.
Warrants And Rights Note Disclosure [Abstract]
Warrants
Warrants And Rights Note Disclosure [Text Block]
The entire disclosure for license agreements.
Research And Development [Abstract]
License Agreements
License Agreements Disclosure [Text Block]
Income Tax Disclosure [Abstract]
Income Taxes
Income Tax Disclosure [Text Block]
Related Party Transactions [Abstract]
Related-Party Transactions
Related Party Transactions Disclosure [Text Block]
Quarterly Financial Information Disclosure [Abstract]
Quarterly Consolidated Financial Data (Unaudited)
Quarterly Financial Information [Text Block]
Impact of COVID-19.
Impact of COVID-19
Impact Of C O V I D19 Policy [Text Block]
Disclosure of accounting policy for significant risks and uncertainties.
Significant Risks and Uncertainties
Significant Risks And Uncertainties Policy Policy [Text Block]
Use of Estimates
Use Of Estimates
Foreign Currency Translation
Foreign Currency Transactions And Translations Policy [Text Block]
Segment and Geographic Information
Segment Reporting Policy Policy [Text Block]
Cash Equivalents
Cash And Cash Equivalents Policy [Text Block]
Concentration of Credit Risk
Concentration Risk Credit Risk
Fair Value of Financial Instruments
Fair Value Of Financial Instruments Policy
Debt Issuance Costs
Debt Policy [Text Block]
Equipment
Property Plant And Equipment Policy [Text Block]
Research and Development Costs
Research And Development Expense Policy
Income Taxes
Income Tax Policy [Text Block]
Stock-Based Compensation
Share Based Compensation Option And Incentive Plans Policy
Disclosure of accounting policy for tax credits.
Tax Credit
Tax Credit Policy Policy [Text Block]
Basic and Diluted Net Loss per Common Share
Earnings Per Share Policy [Text Block]
Leases
Lessee Leases Policy [Text Block]
Recent Accounting Pronouncements
New Accounting Pronouncements Policy Policy [Text Block]
Computation of Basic and Diluted Net Loss per Common Share
Schedule Of Earnings Per Share Basic And Diluted Table [Text Block]
Schedule of Potentially Dilutive Securities
Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Text Block]
Schedule of Accrued Expenses
Schedule Of Accrued Liabilities Table [Text Block]
Schedule of Outstanding Debt and Unamortized Debt Discount Balances
Schedule Of Debt Instruments [Text Block]
Schedule of Principal Payments
Schedule Of Maturities Of Long Term Debt Table [Text Block]
Schedule of operating lease.
Summary of Presentation of Operating Leases
Schedule Of Operating Lease Table [Text Block]
Schedule of Lease Expense
Lease Cost Table [Text Block]
Schedule of Future Minimum Lease Payments of Operating Leases
Lessee Operating Lease Liability Maturity Table [Text Block]
Summary of Stock Option Activity
Schedule Of Share Based Compensation Stock Options Activity Table [Text Block]
Summary of Black-Scholes Option Valuation Assumptions
Schedule Of Share Based Payment Award Stock Options Valuation Assumptions Table [Text Block]
Schedule of RSU Activity
Schedule Of Sharebased Compensation Restricted Stock And Restricted Stock Units Activity Table [Text Block]
Schedule of Stock-Based Compensation Expense Recognized
Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Text Block]
Schedule of Warrant Activity
Schedule Of Stockholders Equity Note Warrants Or Rights [Text Block]
Summary of Initial Fair Value of Warrants Estimated using Black - Scholes Option Pricing Model
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques Table [Text Block]
Schedule of Components of Deferred Tax Assets
Schedule Of Deferred Tax Assets And Liabilities Table [Text Block]
Schedule of Income Tax Rate Reconciliation
Schedule Of Effective Income Tax Rate Reconciliation Table [Text Block]
Summary of Quarterly Consolidated Financial Data
Schedule Of Quarterly Financial Information Table [Text Block]
Represents the number of late-stage candidates included in the Company's product candidate portfolio.
Sale of Stock
Subsidiary Sale Of Stock [Axis]
Sale of Stock
Sale Of Stock Name Of Transaction [Domain]
IPO
I P O [Member]
Number of late-stage candidates in Company's product candidate portfolio
Number Of Late Stage Product Candidates
Accumulated deficit
Segment and Geographic Information
Segment Reporting Disclosure Of Entitys Reportable Segments [Abstract]
Number of operating segments
Number Of Operating Segments
Cash Equivalents
Cash Equivalents At Carrying Value [Abstract]
Cash Equivalents
Cash Equivalents At Carrying Value
Represents the number of financial institutions holding the Company's cash.
Concentration of Credit Risk
Risks And Uncertainties [Abstract]
Number of financial institutions that hold the Company's cash
Number Of Financial Institutions Holding Deposits
Equipment
Property Plant And Equipment [Abstract]
Estimated useful life
Property Plant And Equipment Useful Life
Income Taxes
Effective Income Tax Rate Continuing Operations Tax Rate Reconciliation [Abstract]
Effective tax rate
Effective Income Tax Rate Continuing Operations
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table]
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table]
Class of Warrant or Right
Class Of Warrant Or Right [Axis]
Class of Warrant or Right
Class Of Warrant Or Right [Domain]
Represents common warrants.
Common warrants
Common Warrants [Member]
Represents placement agent warrants.
Placement agent warrants
Placement Agent Warrants [Member]
Measurement Input Type
Measurement Input Type [Axis]
Measurement Input Type
Measurement Input Type [Domain]
Risk Free Interest Rate
Measurement Input Risk Free Interest Rate [Member]
Volatility
Measurement Input Price Volatility [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Common stock to be issued if warrants are exercised (in shares)
Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
Exercise price of warrants (in dollars per share)
Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
Warrant expiration date
Warrants And Rights Outstanding Maturity Date
The fair value of outstanding warrants.
Fair value
Fair Value Of Warrants
Share Price
Share Price
Warrants and Rights Outstanding, Measurement Input
Warrants And Rights Outstanding Measurement Input
Warrant liability
Warrants And Rights Outstanding
Financial liabilities fair value disclosure
Financial Liabilities Fair Value Disclosure
Basic and diluted net loss per common share:
Earnings Per Share Basic And Diluted [Abstract]
Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table]
Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table]
Antidilutive Securities
Antidilutive Securities Excluded From Computation Of Earnings Per Share By Antidilutive Securities [Axis]
Antidilutive Securities, Name
Antidilutive Securities Name [Domain]
Stock Options
Employee Stock Option [Member]
Restricted Stock Units
Restricted Stock Units R S U [Member]
Warrants
Warrant [Member]
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Antidilutive securities
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
Carrying value as of the balance sheet date of obligations incurred through that date and payable for research and development. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Accrued general and administrative current.
Accrued research and development
Accrued Research And Development Current
Accrued compensation
Employee Related Liabilities Current
Accrued general and administrative
Accrued General And Administrative Current
Accrued Interest
Interest Payable Current
Total
Number of days to achieve first milestone following such date.
Number of days to achieve second milestone following such date.
The amount of proceeds from first advance used to repay previous debt.
Line Of Credit Facility [Table]
Line Of Credit Facility [Table]
Debt Instrument
Debt Instrument [Axis]
Debt Instrument, Name
Debt Instrument Name [Domain]
Represents about term loan two thousand twenty.
Term Loan 2020
Term Loan2020 [Member]
Represents about term loan tranche one.
Term loan 2020 tranche one
Term Loan2020 Tranche One [Member]
Represents about term loan tranche two.
Term loan 2020 tranche two
Term Loan2020 Tranche Two [Member]
Represents about term loan tranche three.
Term loan 2020 tranche three
Term Loan2020 Tranche Three [Member]
Represents about term loan tranche four.
Term loan 2020 tranche four
Term Loan2020 Tranche Four [Member]
Represents about term loan tranche five.
Term loan 2020 tranche five
Term Loan2020 Tranche Five [Member]
Scenario
Statement Scenario [Axis]
Scenario
Scenario Unspecified [Domain]
Represents the prepayment of debt occurring prior to first anniversary of closing date.
Prepayment Occurs Prior to First Anniversary of Closing Date
Debt Instrument Prepayment Occurring Prior To First Anniversary Of Closing Date [Member]
Variable Rate
Variable Rate [Axis]
Variable Rate
Variable Rate [Domain]
Prime Rate
Prime Rate [Member]
Represents the information if the outstanding principle and advances under loan agreement exceeds fifty five million.
Outstanding principle and advances under the loans agreement exceeds 55 million
Outstanding Advances Under Loan Agreement Equals Or Exceeds Fifty Five Million [Member]
Statistical Measurement
Range [Axis]
Statistical Measurement
Range [Member]
Minimum
Minimum [Member]
Maximum [Member]
Maximum [Member]
Represents the information if the outstanding principle and advances under loan agreement exceeds fifty five million.
Outstanding principle and advances under the loans agreement exceeds 65 million
Outstanding Advances Under Loan Agreement Equals Or Exceeds Sixty Five Million [Member]
Product and Service
Product Or Service [Axis]
Product and Service
Products And Services [Domain]
Represents the information pertaining to AXS-05 and AXS-07.
AXS-05 and AXS-07
Axs05 And Axs07 [Member]
Represents the prepayment of debt occurring on or after the first anniversary and prior to the second anniversary of the Closing Date.
Prepayment Occurs on or After First Anniversary and Prior to Second Anniversary of the Closing Date
Debt Instrument Prepayment Occurs On Or After First Anniversary And Prior To Second Anniversary Of Closing Date [Member]
Represents the prepayment of debt occurring after the second anniversary and prior to the third anniversary of the Closing Date.
Prepayment Occurs on or After Second Anniversary and Prior to Third Anniversary of Closing Date
Debt Instrument Prepayment Occurs On Or After Second Anniversary And Prior To Third Anniversary Of Closing Date [Member]
This member stands for 2016 Original Term Loan.
Original Term Loan 2016
Original Term Loan2016 [Member]
This member stands for 2016 term loan tranche one.
Term Loan 2016, Tranche One
Term Loan2016 Tranche One [Member]
This member stands for 2016 term loan tranche two and three.
Term Loan 2016, Tranche Two and Three
Term Loan2016 Tranche Two And Three [Member]
This member stands for first amended term loan.
Amended Term Loan 2016
First Amendment Term Loan [Member]
This member stands for Term Loan 2019.
2019 Term Loan
Term Loan2019 [Member]
This member stands for 2019 Term loan Tranche one.
Term Loan 2019, Tranche One
Term Loan2019 Tranche One [Member]
This member stands for 2019 Term loan Tranche Two.
Term Loan 2019, Tranche Two
Term Loan2019 Tranche Two [Member]
Line Of Credit Facility [Line Items]
Line Of Credit Facility [Line Items]
Maximum loan amount
Line Of Credit Facility Maximum Borrowing Capacity
Proceeds from debt
Proceeds From Issuance Of Debt
Remaining credit facility to be drawn
Line Of Credit Facility Remaining Borrowing Capacity
Period to achieve first milestone
Threshold Days To Achieve First Milestone
Period to achieve second milestone
Threshold Days To Achieve Second Milestone
First advance used to repay previous debt
Proceeds From First Advance Used To Repay Previous Debt
Effective cash pay interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.
Represents the multiplier used for the cash pay interest under the debt instrument.
Interest rate basis
Debt Instrument Basis Spread On Variable Rate1
Base interest rate
Debt Instrument Interest Rate Stated Percentage
Cash pay interest rate
Debt Instrument Threshold Cash Pay Interest Rate
Cash pay interest multiplier
Debt Instrument Cash Pay Interest Multiplier
The minimum amount of cash should be maintained as first priority security interest under the terms of debt instrument.
The period of unpaid invoices after threshold period respective amount should be keep as a security under the debt instruments.
Outstanding amount
Long Term Debt
Minimum cash to be maintain as a first priority security interest
Long Term Debt Additional Drawn Covenant Minimum Cash As Security Interest
Period of unpaid invoices amount maintain as security
Long Term Debt Additional Drawn Covenant Additional Security Unpaid Invoices Period
The minimum amount of market capital to be maintained under debt instruments.
The minimum percentage of cash to be maintained as security following the market capitalization conditions under the debt instruments.
The minimum percentage of cash to be maintained under debt instruments.
The minimum percentage of revenue should be achieved under the debt instrument.
Minimum amount of market capital to be maintained
Long Term Debt Additional Drawn Covenant Minimum Market Capitalization Amount
Minimum percentage of cash to be maintained as a security following market capitalization condition
Long Term Debt Additional Drawn Covenant Minimum Cash To Be Maintained As Security With Market Capitalization Covenant Percent
Minimum percentage of cash to be maintained as a security
Long Term Debt Additional Drawn Covenant Minimum Cash To Be Maintained As Security Percent
Minimum product revenue percent
Long Term Debt Additional Drawn Minimum Revenue Percent
The final payment fee at extinguishment of debt.
The final payment fee to be paid under the debt arrangement as a percentage of aggregate amount of all term loan advances minus the aggregate amount of repayments made.
Final payment fee
Extinguishment Of Debt Fee Amount
Percentage of final payment fee
Debt Instrument Final Payment Fee Threshold Percentage Of Debt Outstanding
Represents the prepayment penalty percentage on principal amount of debt.
Percentage of prepayment penalty
Debt Instrument Prepayment Penalty Percentage
Represents the number of loan tranches pertaining to the debt instrument.
Number of loan tranches
Debt Instrument Number Of Loan Tranches
Loan amount
Debt Instrument Face Amount
Repayment of principal on term loan
Interest expense
Interest Expense Debt Excluding Amortization
Amortization of debt issuance costs
Amortization Of Financing Costs
Amount of accreted liability of final payment fee.
Amount, after noncurrent portion of unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.
Outstanding principal amount
Debt Instrument Carrying Amount
Add: accreted liability of final payment fee
Debt Instrument Accreted Liability Of Final Payment Fee
Less: unamortized debt discount, long term
Debt Instrument Unamortized Discount Noncurrent
Less: current portion of long-term debt
Long Term Debt Current Net Of Noncurrent Debt Discount
Loan payable, long-term
Current portion of outstanding principal amount
Less: current portion of unamortized debt discount
Debt Instrument Unamortized Discount Current
Loan payable, current portion
2021
Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
2022
Long Term Debt Maturities Repayments Of Principal In Year Two
2023
Long Term Debt Maturities Repayments Of Principal In Year Three
2024
Long Term Debt Maturities Repayments Of Principal In Year Four
2025
Long Term Debt Maturities Repayments Of Principal In Year Five
Total principal payments outstanding
Loss Contingencies [Table]
Loss Contingencies [Table]
Loss Contingencies [Line Items]
Loss Contingencies [Line Items]
Lease term
Lessee Operating Lease Term Of Contract
Lease commencement date.
Lease commencement date
Lease Commencement Date
Lease, expiration date
Lease Expiration Date1
Lessee, operating lease, description
Lessee Operating Lease Description
Lessee, operating lease, existence of option to extend [true false]
Lessee Operating Lease Existence Of Option To Extend
Lessee, operating lease, option to extend
Lessee Operating Lease Option To Extend
Rent expense
Lease And Rental Expense
Operating lease asset.
Assets
Operating Lease Asset [Abstract]
Liabilities
Operating Lease Liability [Abstract]
Total operating lease liabilities
Operating Lease Liability
Income Statement Location
Income Statement Location [Axis]
Income Statement Location
Income Statement Location [Domain]
General and Administrative
General And Administrative Expense [Member]
Total operating lease expense
Operating Lease Cost
Operating Lease Liabilities Payments Due [Abstract]
2021
Lessee Operating Lease Liability Payments Due Next Twelve Months
2022
Lessee Operating Lease Liability Payments Due Year Two
2023
Lessee Operating Lease Liability Payments Due Year Three
2024
Lessee Operating Lease Liability Payments Due Year Four
2025
Lessee Operating Lease Liability Payments Due Year Five
Thereafter
Lessee Operating Lease Liability Payments Due After Year Five
Total lease payments
Lessee Operating Lease Liability Payments Due
Less imputed interest
Lessee Operating Lease Liability Undiscounted Excess Amount
Present value of operating lease liabilities
Operating lease, remaining lease term
Operating Lease Weighted Average Remaining Lease Term1
Operating lease, discount rate
Operating Lease Weighted Average Discount Rate Percent
The authorized amount under a common stock sales agreement.
The gross sales during the period under a common stock sales agreement.
The commission percentage paid under a common stock sales agreement.
Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]
Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]
Investment, Name
Schedule Of Equity Method Investment Equity Method Investee Name [Axis]
Investment, Name
Equity Method Investee Name [Domain]
SVB Leerink limited liability company.
SVB Leerink
Leerink Partners Limited Liability Company [Member]
Two thousand sixteen shelf registration.
2016 Shelf Registration
Two Thousand Sixteen Shelf Registration [Member]
Two thousand eighteen registered direct offering.
2018 Registered Direct Offering
Two Thousand Eighteen Registered Direct Offering [Member]
Collaborative Arrangement and Arrangement Other than Collaborative
Type Of Arrangement [Axis]
Collaborative Arrangement and Arrangement Other than Collaborative
Arrangements And Nonarrangement Transactions [Member]
December two thousand nineteen sales agreement.
December 2019 Sales Agreement
December Two Thousand Nineteen Sales Agreement [Member]
An underwritten sale of stock.
Underwritten Public Offering
Underwritten Public Offering [Member]
Two thousand nineteen shelf registration.
2019 Shelf Registration
Two Thousand Nineteen Shelf Registration [Member]
Plan Name
Plan Name [Axis]
Plan Name
Plan Name [Domain]
Two thousand thirteen equity compensation plan.
2013 Plan
Two Thousand Thirteen Equity Compensation Plan [Member]
Represents information pertaining to the 2015 Equity Compensation Plan.
2015 Plan
Two Thousand Fifteen Equity Compensation Plan [Member]
Title of Individual
Title Of Individual [Axis]
Title of Individual
Title Of Individual With Relationship To Entity [Domain]
Director
Director [Member]
Award Type
Award Type [Axis]
Award Type
Share Based Compensation Arrangements By Share Based Payment Award Award Type And Plan Name [Domain]
Stock Options
Restricted Stock Units
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Common stock sales agreement, authorized amount
Common Stock Sales Agreement Authorized Amount
Common stock sales agreement, gross sales
Common Stock Sales Agreement Gross Sales
Shares issued
Stock Issued During Period Shares New Issues
Common stock sales agreement, commission percentage
Common Stock Sales Agreement Commission Percentage
Net equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.
The per share exercise price of warrants
The amount utilized for warrants.
Proceeds from issuance of common stock, gross
Stock Issued During Period Value New Issues
Proceeds from issuance of common stock, net
Stock Issued During Period Value New Issues Net
Issuance costs
Payments Of Stock Issuance Costs
Exercise price
Warrant Exercise Price
Warrant utilized
Warrant Utilized
Common stock sales agreement shares unsold amount.
Common stock sales agreement, shares unsold amount
Common Stock Sales Agreement Shares Unsold Amount
Represents the number of votes per share each holder of shares is entitled to.
Common stock, voting right per share
Equity Instrument Voting Rights Per Share
Shares available for future grant
Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
Vesting of stock options
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
Stock-based compensation expense
Allocated Share Based Compensation Expense
Allocated share based compensation expense related to plan cancelled.
Share based compensation arrangement by share based payment award equity instruments other than options cancelled in period.
Stock option to purchase shares of common stock cancelled
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
Non-cash stock-based compensation expense related to plan cancelled
Allocated Share Based Compensation Expense Related To Plan Cancelled
Stock option to purchase shares of common stock cancelled
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Cancelled In Period
Share based compensation arrangement by share based payment award options cancelled in period.
Number of shares
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Roll Forward
Number of shares, Outstanding, beginning balance
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
Number of shares, Granted
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
Number of shares, Exercised
Number of shares, Forfeited
Number of shares, Cancelled
Share Based Compensation Arrangement By Share Based Payment Award Options Cancelled In Period
Number of shares, Outstanding, ending balance
Number of shares, Vested and expected to vest
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
Number of shares, Exercisable
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
Share based compensation arrangements by share based payment award options cancelled in period weighted average exercise price.
Weighted average exercise price
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price Rollforward
Weighted average exercise price, Outstanding, beginning balance
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
Weighted average exercise price, Granted
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
Weighted average exercise price, Exercised
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
Weighted average exercise price, Forfeited
Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
Weighted average exercise price, Cancelled
Share Based Compensation Arrangements By Share Based Payment Award Options Cancelled In Period Weighted Average Exercise Price
Weighted average exercise price, Outstanding, ending balance
Weighted average exercise price, Vested and expected to vest
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
Weighted average exercise price, Exercisable
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
Weighted average contractual term
Share Based Compensation Arrangement By Share Based Payment Award Options Additional Disclosures [Abstract]
Weighted average contractual term, Outstanding
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
Weighted average contractual term, Vested and expected to vest
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
Weighted average contractual term, Exercisable
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
Aggregate intrinsic value
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest [Abstract]
Aggregate intrinsic value, Outstanding
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
Aggregate intrinsic value, Vested and expected to vest
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
Aggregate intrinsic value, Exercisable
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
Black-Scholes option valuation assumptions
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions And Methodology [Abstract]
Risk-free interest rate, minimum
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
Risk-free interest rate, maximum
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
Dividend yield
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
Volatility, minimum
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
Volatility, maximum
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
Weighted average expected term
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
Weighted average grant date fair value
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
Unrecognized compensation cost related to non-vested stock options expected to be recognized
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
Expected vesting period for non-vested share-based compensation
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
Non-vested options outstanding
Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
Intrinsic value of stock options exercised
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
Vesting period
Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
Compensation cost not yet recognized related to unvested RSUs
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options
Weighted average contractual term
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms
Number of shares
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Roll Forward
Number of shares, Outstanding, beginning balance
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
Number of shares, Granted
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
Number of shares, Released
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
Number of shares, Forfeited
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
Number of shares, Cancelled
Number of shares, Outstanding, ending balance
Share based compensation arrangement by share based payment award equity instruments other than options cancelled weighted average grant date fair value.
Weighted average grant date fair value
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value Roll Forward
Weighted average grant date fair value, Outstanding, beginning balance
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
Weighted average grant date fair value, Granted
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
Weighted average grant date fair value, Released
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
Weighted average grant date fair value, Forfeited
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
Weighted average grant date fair value, Cancelled
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Cancelled Weighted Average Grant Date Fair Value
Weighted average grant date fair value, Outstanding, ending balance
Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table]
Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table]
Research and Development
Research And Development Expense [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Class Of Warrant Or Right [Table]
Class Of Warrant Or Right [Table]
Long-term Debt, Type
Longterm Debt Type [Axis]
Long-term Debt, Type
Longterm Debt Type [Domain]
Represents information pertaining to tranche one of convertible notes payable.
September 2014 Notes
Convertible Notes Payable Tranche One [Member]
Information pertaining to 2013 warrants.
2013 Warrants
Warrants2013 [Member]
Class Of Warrant Or Right [Line Items]
Class Of Warrant Or Right [Line Items]
Warrants outstanding
Class Of Warrant Or Right Outstanding
Number of warrants (or share units) issued during the current period.
Number of warrants (or share units) exercised during the current period.
Number of warrants (or share units) expired during the current period.
Warrants outstanding beginning balance
Issued
Warrants Issued In Period
Exercised
Warrants Exercised In Period
Expired
Warrants Expired In Period
Warrants outstanding ending balance
Weighted average price at which warrants were issued.
Weighted average price at which warrants were exercised.
Weighted average price at which warrants expired
Weighted average exercise price, Beginning balance
Issued
Warrants Issued In Period Weighted Average Exercise Price
Exercised
Warrants Exercised In Period Weighted Average Exercise Price
Expired
Warrants Expired In Period Weighted Average Exercise Price
Weighted average exercise price, Ending balance
Percentage of aggregate amount of loan.
Threshold period of specified consecutive trading days within which the volume weighted average price of company's common stock.
Period during which warrants are active, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
Percentage of aggregate amount of loan
Debt Instrument Aggregate Amount Percentage
Trading days
Class Of Warrants Or Rights Weighted Average Price Trading Days
Term of warrants (in years)
Class Of Warrant Or Right Term
Number of warrants exercisable.
Warrants exercisable date
Class Of Warrant Or Righst Date From Which Warrants Or Rights Exercisable
Warrants exercisable
Number Of Warrants Exercisable
Warrants exercised
Warrant term
Warrants And Rights Outstanding Term
The warrant price premium, as a percent of the conversion price, automatically applied as a result of a mandatory conversion.
Fair value of warrant recorded as a debt discount
Debt Instrument Unamortized Discount
Mandatory conversion, warrant price premium as a percent of the conversion price
Class Of Warrant Or Right Mandatory Conversion Price Premium Percentage
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Table]
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Table]
Dividend Yield
Measurement Input Expected Dividend Rate [Member]
Warrants 2020.
2020 Warrants
Warrants2020 [Member]
Information pertaining to 2019 warrants.
2019 Warrants
Warrants2019 [Member]
Information pertaining to 2018 warrants.
2018 Warrants
Warrants2018 [Member]
Information pertaining to 2017 warrants.
2017 Warrants
Warrants2017 [Member]
Information pertaining to 2016 warrants.
2016 Warrants
Warrants2016 [Member]
Information pertaining to 2014 warrants.
2014 Warrants
Warrants2014 [Member]
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]
Represents the consecutive number of trading days to determine the weighted average price per share of ordinary shares.
Initial Cash Payment Per Collaboration Agreement.
Fair value price of a single share of a number of saleable stocks of a company
Fair value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.
Schedule Of Research And Development Arrangement Contract To Perform For Others [Table]
Schedule Of Research And Development Arrangement Contract To Perform For Others [Table]
Counterparty Name
Counterparty Name [Axis]
Counterparty Name
Repurchase Agreement Counterparty Name [Domain]
Information pertaining to Pfizer, Inc.
Pfizer Inc
Pfizer Inc [Member]
Related Party
Related Party Transactions By Related Party [Axis]
Related Party
Related Party [Domain]
Antecip
Affiliated Entity [Member]
Represents information pertaining to AXS-05.
AXS-05
Axs05 [Member]
Research And Development Arrangement Contract To Perform For Others [Line Items]
Research And Development Arrangement Contract To Perform For Others [Line Items]
Number of common shares
Value of common stock
Prior trading days
Consecutive Trading Days
Share price
Upfront cash payment
Initial Cash Payment Per Collaboration Agreement
Fair value share price
Share Price Fair Value
Fair value of common stock
Common Stock Fair Value
Research and development expense recognized
The amount of future payments payable under the collaboration arrangement.
Future milestone payments
Collaboration Arrangement Future Potential Payments
Milestone payments or royalties
Royalty Expense
Represents the number of license agreements the Company has entered into.
Represents the percentage of net sales of products containing the licensed products, due to licensor as a royalty.
Represents the maximum reduction percentage of the royalty due as a result of required payments to third parties.
Period of time, after the first commercial sale of the applicable product, the license agreement is valid, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
Number of exclusive license agreements
Number Of License Agreements
License agreement royalty as a percent of net sales
License Agreement Royalty Due Percentage Of Net Sales
License agreement royalty, maximum reduction percent as a result of required third party payments
License Agreement Royalty Due Maximum Reduction Percentage As Result Of Required Payments To Third Parties
License agreement term, from first commercial sale
License Agreement Term
Operating loss carryforwards expiration year.
Operating Loss Carryforwards [Table]
Operating Loss Carryforwards [Table]
Tax Period
Tax Period [Axis]
Tax Period
Tax Period [Domain]
Tax Year 2017
Tax Year2017 [Member]
Tax Year 2018
Tax Year2018 [Member]
Operating Loss Carryforwards [Line Items]
Operating Loss Carryforwards [Line Items]
NOL carryforwards
Operating Loss Carryforwards
NOL carryforwards expiration year
Operating Loss Carryforwards Expiration Year
Amount, before allocation of valuation allowances, of deferred tax asset attributable to interest expenses.
Amount, before allocation of valuation allowances, of deferred tax asset attributable to charitable contribution.
Deferred tax assets leasing arrangements.
Deferred tax assets:
Deferred Tax Assets Operating Loss Carryforwards Components [Abstract]
Net federal operating loss carryforward
Deferred Tax Assets Operating Loss Carryforwards Domestic
Net foreign operating loss carryforward
Deferred Tax Assets Operating Loss Carryforwards Foreign
Net state operating loss carryforward
Deferred Tax Assets Operating Loss Carryforwards State And Local
Non-cash compensation
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
Research and development credits
Deferred Tax Assets Tax Credit Carryforwards Research
Interest Expense
Deferred Tax Assets Interest Expense
Charitable Contribution
Deferred Tax Assets Charitable Contribution
Fixed Assets
Deferred Tax Assets Property Plant And Equipment
Lease Liability
Deferred Tax Assets Leasing Arrangements
Accrued expenses
Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
Deferred tax asset, excluding valuation allowance
Deferred Tax Assets Gross
Deferred tax liabilities:
Deferred Tax Liabilities Net [Abstract]
Deferred finance costs
Deferred Tax Liabilities Deferred Expense Deferred Financing Costs
Lease Asset
Deferred Tax Liabilities Leasing Arrangements
Deferred tax liability, excluding valuation allowance
Deferred Income Tax Liabilities
Less valuation allowance
Deferred Tax Assets Valuation Allowance
Net deferred tax assets
Deferred Tax Assets Net
Increase in valuation allowance
Valuation Allowance Deferred Tax Asset Change In Amount
Income tax expense (benefit)
Income Tax Expense Benefit
Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to income exempt from income tax because of a permanent differences.
U.S. federal statutory income tax rate
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
State taxes, net of federal benefit
Effective Income Tax Rate Reconciliation State And Local Income Taxes
Stock based compensation - Excess tax benefit
Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
Other permanent differences
Effective Income Tax Rate Reconciliation Permanent Differences Percent
Tax credit
Effective Income Tax Rate Reconciliation Tax Credits
Change in valuation allowance
Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
Effective tax rate
Tax cuts and jobs act net operating loss carryovers and carry backs offset percentage.
CARES Act net operating loss carryback period.
Net operating loss carryovers and carry backs offset percentage
Tax Cuts And Jobs Act Net Operating Loss Carryovers And Carry Backs Offset Percentage
Net operating loss carryback period
C A R E S Act Net Operating Loss Carryback Period
Beneficial ownership percentage.
Schedule Of Related Party Transactions By Related Party [Table]
Schedule Of Related Party Transactions By Related Party [Table]
Dr. Tabuteau
Chief Executive Officer [Member]
Related Party Transaction [Line Items]
Related Party Transaction [Line Items]
Beneficial ownership percentage
Beneficial Ownership Percentage
Total operating expenses